Document is current
Any future updates will be listed below
-
Authors
Nagoshi, Hisao
Toishigawa, Kayo
Inoue, Tomoko
Okikawa, Yoshiko
Miyama, Takahiko
Kawase, Takakazu
Edahiro, Taro
Kazihara, Kyoko
Nakagawa, Hiromi
Yamaoka, Aiko
Noma, Mitsunori
Fujii, Teruhisa
Fukushima, Noriyasu
Ichinohe, Tatsuo https://orcid.org/0000-0002-0393-4066
-
Funding
Funding for this research was provided by:
the Japan Agency for Medical Research and Development (#19ek05100023h0003)
- License Information
-
More Information
Article History
Received: 3 October 2019
Accepted: 27 December 2019
First Online: 7 January 2020
Compliance with ethical standards
: All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent for writing and publishing this report was obtained from the patient included in the study. T. Ichinohe has received speaker honoraria from Bristol-Myers Squibb, Celgene, Janssen Pharmaceutical K.K., and Kyowa Kirin Co. and research funding from Astellas Pharma, Chugai Pharmaceutical Co., CSL Behring, Eisai Co., FUJIFILM Wako Chemicals., Kyowa Kirin Co., Ono Pharmaceutical Co., Pfizer, Nippon Shinyaku Co., MSD, Otsuka Pharmaceutical Co., Repertoire Genesis Inc., Sumitomo Dainippon Pharma Co., Taiho Pharmaceutical Co., Takara Bio Inc., Takeda Pharmaceutical Co., and Zenyaku Kogyo Co. All other authors declare that they have no conflict of interest.
